Navigation auf uzh.ch

Suche

Institut für Medizinische Mikrobiologie

Prof. Dr. Peter Sander

Prof. Dr. Peter Sander, Ph.D.

  • Research Group Leader
Tel.
+41 44 634 26 84

Curriculum vitae

Name Peter Sander
Prof. Dr. rer. nat.
Phone +41 44 634 26 84
psander@imm.uzh.ch
University Degree Diploma in biology, University of Munster, Germany PhD, University of Munster Habilitation, Hannover Medical School, Germany and University of Zurich, Switzerland
Education
1983 – 1990 Studies of biology, University of Munster
1993 Dr. rer. nat. (PhD), University of Munster
2001 Habilitation, Hannover Medical School; venia legendi: Microbiology
2004 Habilitation, University of Zurich; venia legendi: Microbiology
2010 Professor, University of Zurich
   
Professional experience
1990 – 1993 PhD student, Institute for General Zoology and Genetics, University of Munster
1993 – 1998 Postdoc, Department of Medical Microbiology, Hannover Medical School
1998 – 2001 Research Assistant, Department of Medical Microbiology, Hannover Medical School
2001 – today

Principle Investigator and Group leader, Institute of Medical Microbiology, University of Zurich

2018 – 2022 Deputy Head Swiss National Center for Mycobacteria
2022 – today Co-Head Swiss National Center for Mycobacteria
Research area
  • Mycobacterium tuberculosis: Virulence, host-pathogen interaction, protein secretion, lipoprotein synthesis and transport, genetics
  • Vaccine development
  • Antibiotics: drug development, activity, resistance
Awards/Honours Young investigator award of the German Society for Hygiene and Microbiology (DGHM) 2002

List of publications


Promising agents against tuberculosis
UZH-News Jan 6, 2016


Mit langem Atem gegen die Tuberkulose
UZH-News April 22, 2013

Original articles (peer reviewed)

Selected Literature

Review articles

TBVAC2020: Advancing tuberculosis vaccines from discovery to clinical development.
Kaufmann SHE, Dockrell HM, Drager N, Ho MM, McShane H, Neyrolles O, Ottenhoff THM, Patel B, Roordink D, Spertini F, Stenger S, Thole J, Verreck FAW, Williams A; TBVAC2020 Consortium (2017)
Front Immunol 8: 1203

M. tuberculosis lipoproteins in virulence and immunity: fighting with a double-edged sword.
Becker K, Sander P (2016)
FEBS Lett 590: 3800-3819

Developing whole mycobacteria cell vaccines for tuberculosis: Workshop proceedings, Max Planck Institute for Infection Biology, Berlin, Germany, July 9, 2014.
Whole Mycobacteria Cell Vaccines for Tuberculosis Summary Group: Kaufmann S, Bloom B, Brosch R, Cardona P-J, Dockrell H, Fritzell B, Grode L, Hanekom W, Hokey D, Levin M, Martin C, Sander P, Scriba T, Shaligram U, Tameris M, von Reyn F, Walker B, Weiner J, White RG, Schrager L (2015)
Vaccine 33: 3047-55

Lipoprotein synthesis in mycobacteria.
Rezwan M, Grau T, Tschumi A, and Sander P (2007)
Microbiology 153: 652-658.

Mycobacteria: Genetics of resistance and implications for treatment.
Sander P, and Böttger EC (1999)
Chemotherapy 45: 95-108.

Mechanisms of drug resistance in mycobacteria.
Sander P, Meier A, and Böttger EC (1996)
Res Microbiol 147: 59-67.

Book chapters

Bacterial lipoproteins: biogenesis, virulence/pathogenicity and trafficking.
Tokuda H, Sander P, Lee BL, Okuda S, Grau T, Tschumi A, Brülle JK, Kurokawa K, and Nakayama H (2014)
In: Bacterial membranes: Structural and molecular biology. Remaut, H., Fronzes, R. (eds). Caister Academic Press, Norfolk, UK, p. 133 – 177.  

Gene replacement systems in Mycobacterium tuberculosis. In: Tuberculosis and the tubercle bacillus. Eds. Cole, S.T., Eisenach, K.D., McMurray, D.N. and Jacobs, W.R.
Reyrat JM, Sander P, Bardarov S, and Stoker N (2005)
ASM Press, Washington, DC, p. 183-190.

Gene replacement in Mycobacterium tuberculosis and Mycobacterium bovis BCG. In: Methods in Molecular Biology “Mycobacteria Protocols”. Eds. Parish, T., and Stoker, N.G.
Sander P, and Böttger EC (2001)
Humana Press, p. 93-104.

Gene replacement in Mycobacterium smegmatis using a dominant negative selectable marker.
Sander P, and Böttger EC (1998)
Methods Mol Biol 101: 207-216